FFCP PHASE1:Mm9::chr12:104894575..104894613,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=1897|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:104894575..104894613,-|id=chr12:104894575..104894613,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002113!2.22e-13!14;UBERON:0003918!2.22e-13!14;UBERON:0005095!2.22e-13!14;UBERON:0007687!2.22e-13!14;UBERON:0006554!1.17e-11!16;UBERON:0005172!1.49e-11!49;UBERON:0005173!1.49e-11!49;UBERON:0002417!1.49e-11!49;UBERON:0000916!1.49e-11!49;UBERON:0001008!6.01e-11!17;UBERON:0000489!8.83e-09!21;UBERON:0005177!1.06e-08!85;UBERON:0009569!3.60e-08!66;UBERON:0002100!2.74e-07!98;UBERON:0003104!5.38e-07!131;UBERON:0009142!5.38e-07!131|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.25e-13,14;UBERON:0003918,1.25e-13,14;UBERON:0011143,1.25e-13,14;UBERON:0005095,1.25e-13,14;UBERON:0007687,1.25e-13,14;UBERON:0006554,6.81e-11,18;UBERON:0001008,2.18e-10,19;UBERON:0000489,1.61e-09,21|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.649776417447669,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.304465478312141,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114248512609729,0,0,0,0.140271639780637,0.569128834118316,7.67572769493931,1.72698600625512,0.987177311374404,0,0,0,0,0.202860121388503,0,0,0,0,0,0,0,0,0.252578877947112,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.565815239267694,0.295301892880773,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0,0,0,0,0,0,0.108005340821801,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.209613162627982,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:104894575..104894613,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=1897 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:104894575..104894613,- | |||
|description=CAGE_peak_at_chr12:104894575..104894613,- | |||
|id=chr12:104894575..104894613,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002113!2.22e-13!14;UBERON:0003918!2.22e-13!14;UBERON:0005095!2.22e-13!14;UBERON:0007687!2.22e-13!14;UBERON:0006554!1.17e-11!16;UBERON:0005172!1.49e-11!49;UBERON:0005173!1.49e-11!49;UBERON:0002417!1.49e-11!49;UBERON:0000916!1.49e-11!49;UBERON:0001008!6.01e-11!17;UBERON:0000489!8.83e-09!21;UBERON:0005177!1.06e-08!85;UBERON:0009569!3.60e-08!66;UBERON:0002100!2.74e-07!98;UBERON:0003104!5.38e-07!131;UBERON:0009142!5.38e-07!131 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,1.25e-13,14;UBERON:0003918,1.25e-13,14;UBERON:0011143,1.25e-13,14;UBERON:0005095,1.25e-13,14;UBERON:0007687,1.25e-13,14;UBERON:0006554,6.81e-11,18;UBERON:0001008,2.18e-10,19;UBERON:0000489,1.61e-09,21 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.649776417447669,0,0.140444420131752,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.304465478312141,0,0,0,0,0,0,0,0,0,0.484875253135222,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.114248512609729,0,0,0,0.140271639780637,0.569128834118316,7.67572769493931,1.72698600625512,0.987177311374404,0,0,0,0,0.202860121388503,0,0,0,0,0,0,0,0,0.252578877947112,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.565815239267694,0.295301892880773,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0,0,0,0,0,0,0.108005340821801,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.209613162627982,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:104894575..104894613,- | |||
}} |
Latest revision as of 15:03, 4 August 2015
Short description: | p@chr12:104894575..104894613, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:104894575..104894613, - |
Coexpression cluster: | MCL_coexpression_mm9:1897 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 1.25e-13 | 14 |
kidney mesenchyme | 1.25e-13 | 14 |
upper urinary tract | 1.25e-13 | 14 |
kidney rudiment | 1.25e-13 | 14 |
kidney field | 1.25e-13 | 14 |
urinary system structure | 6.81e-11 | 18 |
renal system | 2.18e-10 | 19 |
cavitated compound organ | 1.61e-09 | 21 |